Aurora Expands Patient Access to Medical Cannabis in Canada with Extended Compassionate Pricing Program

Canada's Largest Medical Cannabis Company Offers the Country's Most Inclusive Medical Cannabis Pricing Program

NASDAQ | TSX: ACB

EDMONTON, AB, June 26, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to have recently expanded eligibility of their medical compassionate pricing program in Canada. As part of the company's ongoing commitment to making medical cannabis more accessible to patients, the yearly income eligibility of the program has increased from $40,000 to $60,000 CAD for Aurora patients through AuroraMedical.com.

Read more at prnewswire.com